130 related articles for article (PubMed ID: 2257228)
1. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228
[TBL] [Abstract][Full Text] [Related]
2. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G
Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207
[TBL] [Abstract][Full Text] [Related]
3. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.
Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936
[TBL] [Abstract][Full Text] [Related]
4. Si(IV)-methoxyethylene-glycol-naphthalocyanine: synthesis and pharmacokinetic and photosensitizing properties in different tumour models.
Mantareva V; Shopova M; Spassova G; Wöhrle D; Muller S; Jori G; Ricchelli F
J Photochem Photobiol B; 1997 Oct; 40(3):258-62. PubMed ID: 9372614
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
Busetti A; Soncin M; Jori G; Kenney ME; Rodgers MA
Photochem Photobiol; 1998 Sep; 68(3):377-81. PubMed ID: 9747592
[TBL] [Abstract][Full Text] [Related]
6. Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice.
Guardiano M; Biolo R; Jori G; Schaffner K
Cancer Lett; 1989 Jan; 44(1):1-6. PubMed ID: 2917338
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and tissue distribution studies of the photosensitizer bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC) in normal and tumor-bearing rats.
Zuk MM; Rihter BD; Kenney ME; Rodgers MA; Kreimer-Birnbaum M
Photochem Photobiol; 1994 Jan; 59(1):66-72. PubMed ID: 8127942
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic activities and skin photosensitivity of the bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine in mice.
Brasseur N; Ouellet R; Lewis K; Potter WR; van Lier JE
Photochem Photobiol; 1995 Dec; 62(6):1058-65. PubMed ID: 8570740
[TBL] [Abstract][Full Text] [Related]
9. CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.
Segalla A; Milanesi C; Jori G; Capraro HG; Isele U; Schieweck K
Br J Cancer; 1994 May; 69(5):817-25. PubMed ID: 8180009
[TBL] [Abstract][Full Text] [Related]
10. Hydrophobic Zn(II)-naphthalocyanines as photodynamic therapy agents for Lewis lung carcinoma.
Shopova M; Wohrle D; Stoichkova N; Milev A; Mantareva V; Muller S; Kassabov K; Georgiev K
J Photochem Photobiol B; 1994 Apr; 23(1):35-42. PubMed ID: 8021749
[TBL] [Abstract][Full Text] [Related]
11. Liposome-delivered Zn(II)-2,3-naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic and phototherapeutic studies.
Wöhrle D; Shopova M; Müller S; Milev AD; Mantareva VN; Krastev KK
J Photochem Photobiol B; 1993 Dec; 21(2-3):155-65. PubMed ID: 8301412
[TBL] [Abstract][Full Text] [Related]
12. Effect of delivery system on the pharmacokinetics and tissue distribution of bis(di-isobutyl octadecylsiloxy)silicon 2,3-naphthalocyanine (isoBOSINC), a photosensitizer for tumor therapy.
Zuk MM; Rihter BD; Kenney ME; Rodgers MA; Kreimer-Birnbaum M
Photochem Photobiol; 1996 Jan; 63(1):132-40. PubMed ID: 8577866
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.
Tralau CJ; MacRobert AJ; Coleridge-Smith PD; Barr H; Bown SG
Br J Cancer; 1987 Apr; 55(4):389-95. PubMed ID: 3580264
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine.
Biolo R; Jori G; Soncin M; Pratesi R; Vanni U; Rihter B; Kenney ME; Rodgers MA
Photochem Photobiol; 1994 Mar; 59(3):362-5. PubMed ID: 8016217
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine.
Villanueva A; Jori G
Cancer Lett; 1993 Sep; 73(1):59-64. PubMed ID: 8402599
[TBL] [Abstract][Full Text] [Related]
16. Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.
Milanesi C; Zhou C; Biolo R; Jori G
Br J Cancer; 1990 Jun; 61(6):846-50. PubMed ID: 2372486
[TBL] [Abstract][Full Text] [Related]
17. Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine.
Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
Br J Cancer; 1991 Jul; 64(1):93-5. PubMed ID: 1854632
[No Abstract] [Full Text] [Related]
18. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine.
Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA
J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model.
Chen B; de Witte PA
Cancer Lett; 2000 Mar; 150(1):111-7. PubMed ID: 10755394
[TBL] [Abstract][Full Text] [Related]
20. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
